A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(5 sites)
Australia
Westmead Hospital, Westmead, New South Wales The University of Queensland, Herston, Queensland Calvary Health Care Bethlehem, Parkdale, Victoria The Royal Melbourne Hospital, Parkville, Victoria Perron Institute, Nedlands, Western Australia Last updated February 2025